Category: Ecosystem News

Securisyn Medical Awarded Fourth Air Force Contract for Innovation

By: Colorado BioScience Association   Date: 11/13/2019

Securisyn Medical, LLC, dedicated to inspiring the world to collaborate to make airway management safer, announced today that the United States Air Force (USAF) has awarded the Company a $750,000 Smal...

Learn More

AMPIO PROVIDES UPDATE ON CONTINUED PROGRESS OF AP-013 PHASE III CLINICAL TRIAL AND MANUFACTURING FACILITY

By: Colorado BioScience Association   Date: 11/12/2019

Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) a development stage biopharmaceutical company, executing a Special Protocol Assessment (SPA) Phase III clinical trial titled  “Evaluating the Efficacy...

Learn More

Biodesix Appoints Scott Hutton as Chief Executive Officer

By: Colorado BioScience Association   Date: 11/05/2019

Biodesix, Inc., the leader in lung cancer diagnostic solutions, today announced that current Chief Operating Officer Scott Hutton will become Chief Executive Officer on January 1, 2020. Current CEO Da...

Learn More

IM Therapeutics Is Developing A Novel Targeted Therapy Pipeline in Autoimmune Disease

By: Colorado BioScience Association   Date: 10/28/2019

Type 1 Diabetes Therapy Being Readied for Clinical Trials; Celiac Disease in Drug Development Autoimmune diseases affect about 4% of the world’s population and comprise over 80 disorders, many of whic...

Learn More

SomaLogic significantly expands key strategic collaboration with Novartis

By: Colorado BioScience Association   Date: 10/23/2019

Ten-year agreement with Novartis demonstrates broad and deep commitment to accelerating disease and therapeutic-specific insights based on proprietary proteomic technology Boulder, Colo., USA — SomaLo...

Learn More

Regulatory Affairs Professionals Society (RAPS) Welcomes New RAPS Colorado Chapter

By: Colorado BioScience Association   Date: 10/17/2019

Rockville, MD, USA, Oct. 17, 2019 (GLOBE NEWSWIRE)  The Regulatory Affairs Professionals Society (RAPS) announced the official launch of the RAPS Colorado Chapter. The group first began as a RAPS...

Learn More

Securisyn Medical Receives FDA 510(k) Clearance for its SolidAIRity™ III Airway Stabilization System

By: Colorado BioScience Association   Date: 10/14/2019

HIGHLANDS RANCH – October 9, 2019 – Securisyn Medical, LLC, announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration (“FDA”) to market its SolidAIRity™ III Airw...

Learn More

IM Therapeutics Raises $10 Million Financing Co-Led by JDRF T1D Fund and Morningside Ventures

By: Colorado BioScience Association   Date: 10/09/2019

IM Therapeutics Raises $10 Million Financing Co-Led by JDRF T1D Fund and Morningside Ventures Funding will Advance Lead Drug in Type 1 Diabetes and Develop HLA-Targeted Therapeutic Platform in Autoimm...

Learn More

AmideBio Awarded SBIR Phase II Grant to Further Development of its Novel Glucagons for the Treatment of Hyperinsulinism

By: Colorado BioScience Association   Date: 09/30/2019

BOULDER, CO, September 30, 2019 – AmideBio, LLC, a privately held biopharmaceutical company, announced today that it has received $1.56M in funding through a Phase II Small Business Innovation Researc...

Learn More

GREFFEX, Inc. Awarded $18.7 Million Contract with NIH to Develop a Plug-and-Play Technology Platform to Expedite Production of Vaccine Candidates for Biodefense and Emerging Infectious Diseases

By: Colorado BioScience Association   Date: 09/27/2019

GREFFEX, Inc. (Aurora, CO), a Fitzsimons Innovation Community company, is a transformative leader in genetic engineering. The company was recently awarded an $18.7 million contract with the National I...

Learn More